Low RKIP expression associates with poor prognosis in bladder cancer patients

Virchows Archiv

Volumn 462, Issue 4, 2013, Pages 445-453

  Afonso, Julieta ^a,b   Longatto Filho, Adhemar ^a,b,c   Martinho, Olga ^a,b   Lobo, Francisco ^d   Amaro, Teresina ^d   Reis, Rui M ^a,b,e   Santos, Lúcio L ^f  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^e BARRETOS CANCER HOSPITAL   (Brazil)

^f UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Biomarkers; Bladder cancer; Lymphovascular invasion; Prognosis; RKIP

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY D2-40; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UROTHELIAL BLADDER CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 84876502122     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1388-2     Document Type: Article

References (62)

1. Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239-249
2. Sternberg CN, Donat SM, Bellmunt J et al (2007) Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 69(Suppl 1):62-79 (Pubitemid 46186484)
3. Sternberg CN (2006) Muscle invasive and metastatic bladder cancer. Ann Oncol 17(Suppl 10):23-30 (Pubitemid 44541981)
4. Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279-3290 (Pubitemid 46763021)
5. Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-954 (Pubitemid 34716871)
6. Stoehr R, Brinkmann A, Filbeck T et al (2004) No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract. Oncol Rep 11(Suppl 1):137-141
7. Boulalas I, Zaravinos A, Delakas D, Spandidos DA (2009) Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder. Int J Biol Markers 24(Suppl 1):17-21
8. Karlou M, Saetta AA, Korkolopoulou P et al (2009) Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations. Pathology 41(Suppl 4):327-334
9. Zaravinos A, Chatziioannou M, Lambrou GI et al (2011) Implication of RAF and RKIP genes in urinary bladder cancer. Pathol Oncol Res 17(Suppl2): 181-190
10. Klysik J, Theroux SJ, Sedivy JM, Moffit JS, Boekelheide K (2008) Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 20:1-9 (Pubitemid 350138364)
11. Hellmann J, Rommelspacher H, Mühlbauer E, Wernicke C (2010) Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells. Dev Neurosci 32(1):33-46
12. Eves EM, Shapiro P, Naik K et al (2006) Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 23(4):561-574 (Pubitemid 44205493)
13. Al-Mulla F, Bitar MS, Taqi Z, Rath O, Kolch W (2011) RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility. Mol Biosyst 7(3):928-941
14. Yeung KC, Rose DW, Dhillon AS et al (2001) Raf kinase inhibitor protein interacts witw NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21:7207-7217 (Pubitemid 32953475)
15. Kim SY, Park SG, Jung H et al (2011) RKIP downregulation induces the HBx-mediated Raf-1 mitochondrial translocation. J Microbiol Biotechnol 21(5):525-528
16. Baritaki S, Chapman A, Yeung K et al (2009) Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 28(40):3573-3485
17. Wu K, Bonavida B (2009) The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29(3):241-254
18. Zhu S, Mc Henry KT, Lane WS, Fenteany G (2005) A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration. Chem Biol 12(9):981-991 (Pubitemid 41338808)
19. Yeung K, Janosch P, McFerran B et al (2000) Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20(9):3079-3085 (Pubitemid 30215020)
20. Tang H, Park S, Sun SC et al (2010) RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett 584(4):662-668
21. Lorenz K, Lohse MJ, Quitterer U et al (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426:574-579 (Pubitemid 37522645)
22. Al-Mulla F, Bitar MS, Al-Maghrebi M et al (2011) Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β. Cancer Res 71(4):1334-1343
23. Fu Z, Smith PC, Zhang L (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878-879
24. Hagan S, Al-Mulla F, Mallon E (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11:7392-7397 (Pubitemid 41507699)
25. Al-Mulla F, Hagan S, Behbehani AI (2006) Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24:5672-5679 (Pubitemid 46631308)
26. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK (2004) Reduction of Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64:5186-5192 (Pubitemid 39006537)
27. Afonso J, Santos LL, Amaro T, Lobo F, Longatto-Filho A (2009) The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion - the prognostic contribution of related molecular markers. Histopathology 55:514-524
28. Amin MB, Srigley JR, Grignon DJ et al (2005) Urinary bladder cancer protocols and checklists. College of American Pathologists, Northfield
29. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York
30. Mostofi CJ, Davis CJ, Sesterhenn IA (1999) World Health Organization, International Histological Classification of Tumours. Histological typing of urinary bladder tumours. Springer, Berlin
31. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organ. IARC Press, Lyon
32. Martinho O, Gouveia A, Silva P et al (2009) Loss of RKIP expression is associated with poor survival in GISTs. Virchows Arch 455(Suppl 3):277-284
33. Martinho O, Faloppa CC, Neto CS et al (2012) Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. J Clin Pathol 65(Suppl 2):122-128
34. Martinho O, Granja S, Jaraquemada T et al (2012) Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS One 7(1):e30769
35. Bevilacqua E, Frankenberger CA, Rosner MR (2012) RKIP suppresses breast cancer metastasis to the bone by regulating stroma-associated genes. Int J Breast Cancer 2012:124704
36. Hao C, Wei S, Tong Z et al (2012) The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro. Tumour Biol 33(Suppl 4):1159-1167
37. Xinzhou H, Ning Y, Ou W et al (2011) RKIP inhibits the migration and invasion of human prostate cancer PC-3 M cells through regulation of extracellular matrix. Mol Biol (Mosk) 45(Suppl 6):1004-1011
38. Beshir AB, Ren G, Magpusao AN et al (2010) Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett 299(Suppl 2):137-149
39. Beach S, Tang H, Park S et al (2008) Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 27(Suppl 15):2243-2248 (Pubitemid 351483382)
40. Thuault S, Valcourt U, Petersen M et al (2006) Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174(2):175-183 (Pubitemid 44079853)
41. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21(9):1025-1030 (Pubitemid 46686471)
42. Dangi-Garimella S, Yun J, Eves EM et al (2009) Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 28(4):347-358
43. Yun J, Frankenberger CA, Kuo WL et al (2011) Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 30(21):4500-4514
44. Zhang L, Fu Z, Binkley C et al (2004) Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 136:708-715 (Pubitemid 39186587)
45. Li HZ, Wang Y, Gao Y et al (2008) Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6(Suppl 6):917-928
46. Wang J, Yang YH, Wang AQ (2010) Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 27(Suppl 2):219-223
47. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M (2006) Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 131(Suppl 4):1208-1217 (Pubitemid 44498689)
48. Hu CJ, Zhou L, Zhang J, Huang C, Zhang GM (2011) Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue. J Int Med Res 39(Suppl 1):229-237
49. Kim HS, Won KY, Kim GY et al (2012) Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma. Pathol Res Pract 208(Suppl 5):292-299
50. Kim HS, Lee SH, Won KY (2012) Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater. Virchows Arch 460(Suppl 1):61-68
51. Fu Z, Kitagawa Y, Shen R et al (2006) Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66:248-256 (Pubitemid 43191224)
52. Chatterjee D, Sabo E, Tavares R, Resnick MB (2008) Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 14(Suppl 10):2994-3001
53. Gao C, Pang L, Ren C, Ma T (2012) Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma. Pathol Oncol Res 18(Suppl 2):471-477
54. Kim HS, Kim GY, Lim SJ, Kim YW (2010) Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma. Pathology 42(Suppl 7):655-660
55. Kim HS, Kim GY, Lim SJ, Park YK, Kim YW (2010) Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma. Hum Pathol 41(Suppl 11):1609-1616
56. Chatterjee D, Bai Y, Wang Z et al (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279(Suppl 17):17515-17523 (Pubitemid 38560515)
57. Ruan L, Wang GL, Yi H, Chen Y et al (2010) Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110(Suppl 4):975-981
58. Woods Ignatoski KM, Grewal NK, Markwart SM et al (2008) Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. Int J Radiat Oncol Biol Phys 72(Suppl 1):153-160
59. Al-Mulla F, Hagan S, Al-Ali W (2008) Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61(Suppl 4):524-529 (Pubitemid 351518239)
60. Minoo P, Baker K, Goswami R (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55(Suppl 10):1467-1474 (Pubitemid 44476793)
61. Ren G, Baritaki S, Marathe H et al (2012) Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 72(12):3091-3104
62. Al-Mulla F, Bitar MS, Feng J, Park S, Yeung KC (2012) A new model for raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One 7(1):e29532